BioMarin Pharmaceutical - 20 Year Stock Price History | BMRN

Historical daily share price chart and data for BioMarin Pharmaceutical since 1999 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for BioMarin Pharmaceutical as of March 21, 2019 is 90.78.
BioMarin Pharmaceutical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 93.1413 84.9600 98.6200 84.2000 90.7800 6.61%
2018 92.1163 91.0300 106.0700 76.0100 85.1500 -4.51%
2017 88.8143 85.8400 98.8200 80.6000 89.1700 7.64%
2016 86.6998 104.9200 104.9200 64.7400 82.8400 -20.92%
2015 117.0456 92.1700 149.1300 90.2800 104.7600 15.88%
2014 70.7528 69.2700 94.1900 55.7800 90.4000 28.50%
2013 63.4324 51.9200 78.3880 51.5600 70.3500 42.99%
2012 39.1417 34.9300 50.1700 32.1300 49.2000 43.11%
2011 28.4184 26.6100 35.3800 23.4600 34.3800 27.66%
2010 22.1536 18.9500 28.2500 18.2400 26.9300 43.17%
2009 15.6685 17.6500 20.8300 10.1400 18.8100 5.67%
2008 29.7800 36.6400 40.3900 13.5900 17.8000 -49.72%
2007 21.0564 16.1000 36.5800 15.7100 35.4000 115.99%
2006 14.3090 10.9900 18.0400 10.9600 16.3900 52.04%
2005 7.3643 6.2600 11.4100 4.4300 10.7800 68.70%
2004 6.2104 7.9100 8.7900 3.8700 6.3900 -17.65%
2003 9.4456 7.0300 13.3200 6.4100 7.7600 10.07%
2002 7.2827 13.2400 13.9500 3.6500 7.0500 -47.54%
2001 11.0435 9.5000 14.1600 7.3130 13.4400 38.73%
2000 18.0555 12.7500 38.7500 7.1560 9.6880 -17.55%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $16.046B $1.491B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $118.930B 13.26
Gilead Sciences (GILD) United States $82.398B 10.49
Biogen (BIIB) United States $63.063B 12.22
Celgene (CELG) United States $62.067B 11.48
Illumina (ILMN) United States $46.349B 55.12
Vertex Pharmaceuticals (VRTX) United States $46.013B 61.64
Regeneron Pharmaceuticals (REGN) United States $44.311B 20.58
Alexion Pharmaceuticals (ALXN) United States $29.422B 18.24
Incyte (INCY) United States $18.475B 172.62
Seattle Genetics (SGEN) United States $11.684B 0.00
Exact Sciences (EXAS) United States $11.379B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.423B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.298B 53.05
QIAGEN (QGEN) Netherlands $9.023B 29.86
Sarepta Therapeutics (SRPT) United States $8.830B 0.00
Bluebird Bio (BLUE) United States $8.439B 0.00
BeiGene (BGNE) Cayman Islands $7.982B 0.00
Guardant Health (GH) United States $7.569B 0.00
Bio-Techne Corp (TECH) United States $7.497B 50.51
Exelixis (EXEL) United States $7.317B 17.05
Moderna (MRNA) United States $6.580B 0.00
Amarin (AMRN) Ireland $6.139B 0.00
Alkermes (ALKS) Ireland $5.391B 0.00
Array BioPharma (ARRY) United States $5.335B 0.00
Galapagos (GLPG) Belgium $5.290B 0.00
Ascendis Pharma (ASND) Denmark $5.228B 0.00
Horizon Pharma Public (HZNP) Ireland $4.729B 15.23
Spark Therapeutics (ONCE) United States $4.309B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.246B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.773B 0.00
Blueprint Medicines (BPMC) United States $3.677B 0.00
Immunomedics (IMMU) United States $3.494B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.490B 0.00
China Biologic Products (CBPO) China $3.441B 21.32
Intercept Pharmaceuticals (ICPT) United States $3.358B 0.00
Allogene Therapeutics (ALLO) United States $3.154B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.026B 0.00
Amicus Therapeutics (FOLD) United States $2.991B 0.00
Global Blood Therapeutics (GBT) United States $2.881B 0.00
Reata Pharmaceuticals (RETA) United States $2.710B 0.00
Genomic Health (GHDX) United States $2.709B 69.26
Repligen (RGEN) United States $2.612B 80.38
Akcea Therapeutics (AKCA) United States $2.587B 0.00
Mirati Therapeutics (MRTX) United States $2.566B 0.00
Ligand Pharmaceuticals (LGND) United States $2.529B 18.89
UniQure (QURE) Netherlands $2.477B 0.00
Emergent Biosolutions (EBS) United States $2.469B 20.61
Myriad Genetics (MYGN) United States $2.421B 24.66
Halozyme Therapeutics (HALO) United States $2.399B 0.00
Acceleron Pharma (XLRN) United States $2.338B 0.00
Insmed (INSM) United States $2.223B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.209B 0.00
REGENXBIO (RGNX) United States $2.207B 23.04
Arena Pharmaceuticals (ARNA) United States $2.203B 0.00
MyoKardia (MYOK) United States $2.197B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.181B 0.00
Denali Therapeutics (DNLI) United States $2.083B 0.00
Medicines (MDCO) United States $1.998B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.940B 0.00
AnaptysBio (ANAB) United States $1.915B 0.00
NeoGenomics (NEO) United States $1.838B 149.54
Atara Biotherapeutics (ATRA) United States $1.794B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.745B 0.00
Myovant Sciences (MYOV) United Kingdom $1.720B 0.00
Audentes Therapeutics (BOLD) United States $1.644B 0.00
Allakos (ALLK) United States $1.641B 0.00
Puma Biotechnology (PBYI) United States $1.520B 0.00
WAVE Life Sciences (WVE) Singapore $1.509B 0.00
GOSSAMER BIO (GOSS) United States $1.472B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.452B 0.00
Innoviva (INVA) United States $1.409B 3.88
Momenta Pharmaceuticals (MNTA) United States $1.356B 0.00
Clovis Oncology (CLVS) United States $1.338B 0.00
Aimmune Therapeutics (AIMT) United States $1.315B 0.00
Rubius Therapeutics (RUBY) United States $1.306B 0.00
Cambrex (CBM) United States $1.299B 13.99
ALECTOR INC (ALEC) United States $1.292B 0.00
Lion Biotechnologies (IOVA) United States $1.237B 0.00
Apellis Pharmaceuticals (APLS) United States $1.206B 0.00
Editas Medicine (EDIT) United States $1.184B 0.00
Fate Therapeutics (FATE) United States $1.147B 0.00
Codexis (CDXS) United States $1.141B 0.00
Epizyme (EPZM) United States $1.085B 0.00
InflaRx (IFRX) Germany $1.081B 0.00
RA PHARMCTL INC (RARX) United States $1.057B 0.00
Coherus BioSciences (CHRS) United States $1.045B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.041B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.987B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.985B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.980B 0.00
Retrophin (RTRX) United States $0.977B 0.00
Sangamo Therapeutics (SGMO) United States $0.975B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.943B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.942B 38.08
Dicerna Pharmaceuticals (DRNA) United States $0.929B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.922B 0.00
Principia Biopharma (PRNB) United States $0.869B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.833B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.823B 0.00
Athenex (ATNX) United States $0.814B 0.00
Vericel (VCEL) United States $0.810B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.800B 0.00
Cellectis (CLLS) France $0.794B 0.00
Eidos Therapeutics (EIDX) United States $0.770B 0.00
Intellia Therapeutics (NTLA) United States $0.767B 0.00
Cara Therapeutics (CARA) United States $0.766B 0.00
ANI Pharmaceuticals (ANIP) United States $0.764B 13.98
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.708B 0.00
Revance Therapeutics (RVNC) United States $0.699B 0.00
Intra-Cellular Therapies (ITCI) United States $0.694B 0.00
Synthorx (THOR) United States $0.670B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.670B 0.00
Osiris Therapeutics (OSIR) United States $0.664B 0.00
Twist Bioscience (TWST) United States $0.652B 0.00
Acorda Therapeutics (ACOR) United States $0.652B 8.45
Heska (HSKA) United States $0.647B 57.99
Magenta Therapeutics (MGTA) United States $0.597B 0.00
Viking Therapeutics (VKTX) United States $0.595B 0.00
Kura Oncology (KURA) United States $0.586B 0.00
ObsEva SA (OBSV) Switzerland $0.581B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.580B 0.00
Stemline Therapeutics (STML) United States $0.566B 0.00
G1 THERAPEUTICS (GTHX) United States $0.562B 0.00
Cytokineticsorporated (CYTK) United States $0.559B 0.00
Arvinas (ARVN) United States $0.546B 0.00
Zealand Pharma (ZEAL) Denmark $0.545B 6.00
Prothena (PRTA) Ireland $0.544B 0.00
MeiraGTx Holdings (MGTX) United States $0.539B 0.00
UROGEN PHARMA (URGN) Israel $0.516B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.516B 0.00
Arcus Biosciences (RCUS) United States $0.514B 0.00
Scholar Rock Holding (SRRK) United States $0.498B 0.00
Zymeworks (ZYME) Canada $0.494B 0.00
DBV Technologies (DBVT) France $0.486B 0.00
CytomX Therapeutics (CTMX) United States $0.484B 0.00
Dynavax Technologies (DVAX) United States $0.482B 0.00
PDL BioPharma (PDLI) United States $0.474B 10.57
Five Prime Therapeutics (FPRX) United States $0.466B 0.00
Mesoblast (MESO) Australia $0.451B 0.00
Replimune (REPL) United States $0.447B 0.00
AVROBIO (AVRO) United States $0.446B 0.00
Senesco Technologies (ELOX) United States $0.436B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.433B 0.00
Sorrento Therapeutics (SRNE) United States $0.427B 0.00
Anika Therapeutics (ANIK) United States $0.424B 16.03
Achillion Pharmaceuticals (ACHN) United States $0.415B 0.00
MannKind (MNKD) United States $0.414B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.407B 0.00
BeyondSpring (BYSI) United States $0.400B 0.00
Axsome Therapeutics (AXSM) United States $0.400B 0.00
XBiotech (XBIT) United States $0.397B 0.00
Agenus (AGEN) United States $0.389B 0.00
Solid Biosciences (SLDB) United States $0.378B 0.00
UNITY Biotechnology (UBX) $0.378B 0.00
Abeona Therapeutics (ABEO) United States $0.377B 0.00
BioDelivery Sciences (BDSI) United States $0.374B 0.00
STEALTH BIOTHER (MITO) United States $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Adverum Biotechnologies (ADVM) United States $0.369B 0.00
Albireo Pharma (ALBO) United States $0.368B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
MediciNova (MNOV) United States $0.360B 0.00
Urovant Sciences (UROV) United States $0.353B 0.00
Inovio Pharmaceuticals (INO) United States $0.351B 0.00
Kezar Life Sciences (KZR) United States $0.351B 0.00
Gritstone Oncology (GRTS) United States $0.340B 0.00
Kindred Biosciences (KIN) United States $0.338B 0.00
Geron (GERN) United States $0.330B 0.00
Cellular Biomedicine (CBMG) United States $0.329B 0.00
OSMOTICA PHARM (OSMT) United States $0.329B 0.00
Krystal Biotech (KRYS) United States $0.320B 0.00
Aduro Biotech (ADRO) United States $0.312B 0.00
Protagonist Therapeutics (PTGX) United States $0.307B 0.00
AC Immune SA (ACIU) Switzerland $0.306B 0.00
Syros Pharmaceuticals (SYRS) United States $0.300B 0.00
Strongbridge Biopharma (SBBP) United States $0.300B 0.00
Merus (MRUS) Netherlands $0.292B 0.00
Constellation Pharmaceuticals (CNST) United States $0.292B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.285B 0.00
Gamida Cell (GMDA) Israel $0.284B 0.00
Novavax (NVAX) United States $0.283B 0.00
Kala Pharmaceuticals (KALA) United States $0.279B 0.00
Enochian BioSciences (ENOB) United States $0.278B 0.00
Seres Therapeutics (MCRB) United States $0.277B 0.00
Evelo Biosciences (EVLO) United States $0.269B 0.00
Verastem (VSTM) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.257B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.256B 0.00
TOCAGEN INC (TOCA) United States $0.251B 0.00
Cerecor (CERC) United States $0.250B 0.00
BioTime (BTX) United States $0.245B 0.00
Avid Bioservices (CDMO) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.244B 0.00
Kamada (KMDA) Israel $0.238B 10.74
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Athersys (ATHX) United States $0.231B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.231B 0.00
Spero Therapeutics (SPRO) United States $0.226B 0.00
Celyad SA (CYAD) Belgium $0.223B 0.00
Axovant Sciences (AXGT) United Kingdom $0.222B 0.00
Intec Pharma (NTEC) Israel $0.222B 0.00
Proteostasis Therapeutics (PTI) United States $0.221B 0.00
Mersana Therapeutics (MRSN) United States $0.219B 0.00
LogicBio Therapeutics (LOGC) United States $0.219B 0.00
ChromaDex (CDXC) United States $0.215B 0.00
Liquidia Technologies (LQDA) United States $0.213B 0.00
Arbutus Biopharma (ABUS) Canada $0.210B 0.00
Palatin Technologies (PTN) United States $0.205B 101.00
Celcuity (CELC) United States $0.203B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.202B 0.00
Synlogic (SYBX) United States $0.201B 0.00
VBI Vaccines (VBIV) United States $0.194B 0.00
Compugen (CGEN) Israel $0.193B 0.00
Cue Biopharma (CUE) United States $0.193B 0.00
Pfenex (PFNX) United States $0.192B 0.00
OvaScience (MLND) United States $0.188B 0.00
Menlo Therapeutics (MNLO) United States $0.182B 0.00
CorMedix Inc (CRMD) United States $0.182B 0.00
ADMA Biologics Inc (ADMA) United States $0.181B 0.00
ResTORbio (TORC) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.177B 0.00
Trevena (TRVN) United States $0.171B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.159B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.154B 0.00
BioXcel Therapeutics (BTAI) United States $0.154B 0.00
PHASEBIO PHARMA (PHAS) United States $0.153B 0.00
Chiasma (CHMA) United States $0.152B 0.00
Allena Pharmaceuticals (ALNA) United States $0.150B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.144B 0.00
Anavex Life Sciences (AVXL) United States $0.141B 0.00
Unum Therapeutics (UMRX) United States $0.139B 0.00
Cohbar (CWBR) United States $0.138B 0.00
Eton Pharmaceuticals (ETON) United States $0.137B 0.00
Aptinyx (APTX) United States $0.134B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.128B 0.00
Equillium (EQ) United States $0.127B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.127B 0.00
Enzo Biochem (ENZ) United States $0.124B 0.00
Fortress Biotech (FBIO) United States $0.122B 0.00
Selecta Biosciences (SELB) United States $0.121B 0.00
XOMA (XOMA) United States $0.120B 0.00
Catalyst Biosciences (CBIO) United States $0.116B 0.00
Pluristem Therapeutics (PSTI) Israel $0.115B 0.00
Mustang Bio (MBIO) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.111B 0.00
VolitionRX (VNRX) Singapore $0.110B 0.00
Signal Genetics (MGEN) United States $0.105B 0.00
NantKwest (NK) United States $0.104B 0.00
Neothetics (EVFM) United States $0.104B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.097B 0.00
Cel-Sci (CVM) United States $0.095B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.092B 0.00
Provention Bio (PRVB) United States $0.090B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.086B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.086B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.083B 93.00
Brainstorm Cell Therapeutics (BCLI) United States $0.083B 0.00
Oncobiologics (OTLK) United States $0.081B 0.00
Alimera Sciences (ALIM) United States $0.080B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.080B 0.00
NewLink Genetics (NLNK) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.079B 0.00
Applied Genetic Technologies (AGTC) United States $0.077B 0.00
INMUNE BIO INC (INMB) United States $0.077B 0.00
SESEN BIO, INC (SESN) United States $0.075B 0.00
OVID THERAPEUTC (OVID) United States $0.073B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
Protalix BioTherapeutics (PLX) Israel $0.071B 0.00
AEterna Zentaris (AEZS) United States $0.069B 13.16
Prima BioMed (IMMP) Australia $0.066B 0.00
Eyenovia (EYEN) United States $0.065B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.064B 0.00
Ophthotech (OPHT) United States $0.064B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.063B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Proteon Therapeutics (PRTO) United States $0.062B 0.00
Vascular Biogenics (VBLT) Israel $0.061B 0.00
Celldex Therapeutics (CLDX) United States $0.060B 0.00
Alcobra (ARCT) United States $0.059B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Zosano Pharma (ZSAN) United States $0.057B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.057B 0.00
Arsanis (XFOR) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.054B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
ANCHIANO THERAP (ANCN) Israel $0.050B 0.00
Vaccinex (VCNX) United States $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.049B 0.00
Evogene (EVGN) Israel $0.049B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Entera Bio (ENTX) Israel $0.048B 0.00
Bionano Genomics (BNGO) United States $0.048B 0.00
Curis (CRIS) United States $0.046B 0.00
TRACON Pharmaceuticals (TCON) United States $0.046B 0.00
Leap Therapeutics (LPTX) United States $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.043B 0.00
Celsion (CLSN) United States $0.041B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
Motif Bio Plc (MTFB) United States $0.037B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.036B 0.00
Caladrius Biosciences (CLBS) United States $0.036B 0.00
Aptevo Therapeutics (APVO) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoSec Medical (ONCS) United States $0.035B 0.00
AquaBounty Technologies (AQB) United States $0.035B 0.00
Sophiris Bio (SPHS) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
GTx (GTXI) United States $0.031B 0.00
Aileron Therapeutics (ALRN) United States $0.031B 0.00
Galena Biopharma (SLS) United States $0.030B 0.00
BioPharmX (BPMX) United States $0.029B 0.00
Adial Pharmaceuticals (ADIL) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
Vical (VICL) United States $0.026B 0.00
Oragenics (OGEN) United States $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.025B 0.00
CytRx (CYTR) United States $0.025B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
Fibrocell Science Inc (FCSC) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Benitec Biopharma (BNTC) Australia $0.022B 0.00
Dare Bioscience (DARE) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
TrovaGene (TROV) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.54
Genetic Technologies (GENE) Australia $0.015B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Apricus Biosciences (SEEL) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Pulmatrix (PULM) United States $0.012B 0.00
Neuralstem (CUR) United States $0.012B 0.00
Synthetic Biologics (SYN) United States $0.012B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Histogenics (HSGX) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00